Re: Remdesivir for the treatment of COVID-19 by Lee et al
- PMID: 36206865
- PMCID: PMC9531359
- DOI: 10.1016/j.cmi.2022.09.015
Re: Remdesivir for the treatment of COVID-19 by Lee et al
Comment in
-
Remdesivir for the treatment of COVID-19: author's response.Clin Microbiol Infect. 2023 Jan;29(1):115-117. doi: 10.1016/j.cmi.2022.09.020. Epub 2022 Oct 4. Clin Microbiol Infect. 2023. PMID: 36206866 Free PMC article. No abstract available.
Comment on
-
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis.Clin Microbiol Infect. 2022 Sep;28(9):1203-1210. doi: 10.1016/j.cmi.2022.04.018. Epub 2022 May 19. Clin Microbiol Infect. 2022. PMID: 35598856 Free PMC article.
References
-
- Lee T.C., Murhty S., Del Corpo O., Senecal J., Butler-Laporte G., Sohani Z.N., et al. Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:1203–1210. https://doi:10.1016/j.cmi.2022.04.018 - DOI - PMC - PubMed
-
- Abd-Elsalam S. Retraction notice. Am J Trop Med Hyg. 2022;103:1635–1639. https://doi: 10.4269/ajtmh.1073ret - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical